Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
IN8BIO INAB Private Placement; Cardio Diagnostics CDIO Pricing Determinations
Cardio Diagnostics: PrecisionCHD,Epi+Gen CHD Get Pricing Determinations From CMS
Express News | Cardio Diagnostics Receives Preliminary Medicare Pricing From CMS For AI-Powered Cardiovascular Tests, Marking Key Milestone Toward Securing Medicare Reimbursement For PrecisionCHD And Epi+Gen CHD
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing From Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
12 Health Care Stocks Moving In Thursday's After-Market Session
Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests
10-Q: Q2 2024 Earnings Report
Express News | Cardio Diagnostics Launches Redesigned Website At CDIO.AI, Highlighting AI-Powered Solutions For Cardiovascular Disease Prevention, Detection, And Management; Streamlines Access For Investors, Partners, Patients, Providers, And Stakeholders
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
Cardio Diagnostics Says Epi-Gen CHD Heart Attack Risk Assessment Test Now Available At Meijer In McHenry, Illinois
Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum
AI Is Helping Cat Owners In Tokyo Keep Their Feline Friends Healthier: App Can Reportedly Detect Pain With More Than 95% Accuracy
Express News | Cardio Diagnostics Holdings, Inc. Achieves Soc 2 Type I Compliance Certification for Security and Confidentiality
Express News | Cardio Diagnostics Holdings Achieves SOC 2 Type I Compliance Certification For Security And Confidentiality
Express News | Cardio Diagnostics Holdings Inc -on June 3, Got Notice From Nasdaq, Company Is No Longer in Compliance With Nasdaq Listing Rule 5550(a)(2)
Benchmark Co. Maintains Cardio Diagnostics(CDIO.US) With Buy Rating, Raises Target Price to $2
Express News | Cardio Diagnostics Holdings Inc : Benchmark Raises Target Price to $2
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
10-Q: Q1 2024 Earnings Report
No Data
No Data